Role of oral doxycycline in the management of conjunctival dehiscence following glaucoma drainage device

Prakrati Gupta; Srisha Senthil; Arjun Srirampur; Priya Mittal

doi:10.18203/2349-2902.isj20172801

Authors

Prakrati Gupta Department of Glaucoma, LV Prasad Eye Institute, Vijayawada, Andhra Pradesh, India
Srisha Senthil Head of Glaucoma services, KAR campus, L V Prasad Eye Institute, Hyderabad, Telangana, India
Arjun Srirampur Department of Cornea, LV Prasad Eye Institute, Vijayawada, Andhra Pradesh, India
Priya Mittal Department of Glaucoma, LV Prasad Eye Institute, Vijayawada, Andhra Pradesh, India

DOI:

https://doi.org/10.18203/2349-2902.isj20172801

Keywords:

Ahmed glaucoma valve, Doxycycline, Glaucoma drainage devices, Penetrating keratoplasty

Abstract

Importance of matrix metalloproteinase inhibitor like Doxycycline in the management of conjunctival dehiscence following glaucoma drainage device. A 50 years old man developed conjunctival retraction after a glaucoma grainage device with was managed with oral doxycycline. After 4 month of continuous treatment there was complete healing of conjunctival defect. Oral doxycycline is a viable alternative in the conservative management of conjunctival retraction obviating the need for surgical intervention.

Metrics

Metrics Loading ...

References

Chan JE, Netland PA. Ex-press glaucoma filtration device: efficacy, safety, and predictability. Med Devices (Auckl). 2015;8:381-8.

Parihar JK, Vats DP, Maggon R, Mathur V, Singh A, Mishra SK. The efficacy of Ahmed glaucoma valve drainage devices in cases of adult refractory glaucoma in Indian eyes. Indian J Ophthalmol. 2009;57(5):345-50.

Geffen N, Buys YM, Smith M, Anraku A, Alasbali T, Rachmiel R, et al. Conjunctival complications related to Ahmed glaucoma valve insertion. J Glaucoma. 2014;23:109-14.

Smith VA, Cook SD. Doxycycline-a role in ocular surface repair. Br J Ophthalmol. 2004;88:619-25.

Wong TT, Sethi C, Daniels JT, Limb GA, Murphy G, Khaw PT. Matrix metalloproteinases in disease and repair processes in the anterior segment. Surv Ophthalmol. 2002;47:239-56.

Dursun D1, Kim MC, Solomon A, Pflugfelder SC. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteina. Am J Ophthalmol. 2001;132(1):8-13.

Garrana RM, Zieske MA, Assouline M, Gipson IK. Matrix metalloproteinases in epithelia from human recurrent corneal erosion. Invest Ophthalmol Vis Sci. 1999;40:1266-70.

Solomon A1, Rosenblatt M, Li DQ, Liu Z, Monroy D, Ji Z, Lokeshwar BL, et al. Doxycycline inhibition of interleukin-1 in the corneal epithelium. Invest Ophthalmol Vis Sci. 2000;41:2544-57.